{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:40:00Z","timestamp":1773772800786,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10354-008-0589-9","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T01:56:25Z","timestamp":1228269385000},"page":"621-626","source":"Crossref","is-referenced-by-count":8,"title":["Opioidinduzierte Obstipation: Literaturanalyse zu Pathophysiologie und Behandlung","Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment"],"prefix":"10.1007","volume":"158","author":[{"given":"J\u00fcrgen","family":"Osterbrink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"589_CR1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1592\/phco.22.3.240.33552","volume":"22","author":"CM Herndon","year":"2002","unstructured":"Herndon CM, Jackson KC, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy, 22: 240\u2013250, 2002","journal-title":"Pharmacotherapy"},{"key":"589_CR2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neulet.2003.12.004","volume":"361","author":"P Holzer","year":"2004","unstructured":"Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett, 361: 192\u2013195, 2004","journal-title":"Neurosci Lett"},{"key":"589_CR3","first-page":"61","volume":"15","author":"S O'Mahony","year":"2001","unstructured":"O'Mahony S, Coyle N, Payne R. Current management of opioid-related side effects. Oncology (Williston Park), 15: 61\u201373, discussion 77\u201378, 80\u201382, 2001","journal-title":"Oncology (Williston Park)"},{"key":"589_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9610(01)00782-6","volume":"182","author":"M Pappagallo","year":"2001","unstructured":"Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg, 182: 11\u201318, 2001","journal-title":"Am J Surg"},{"key":"589_CR5","first-page":"1347","volume":"74","author":"JM Swegle","year":"2006","unstructured":"Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician, 74: 1347\u20131354, 2006","journal-title":"Am Fam Physician"},{"key":"589_CR6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","volume":"112","author":"E Kalso","year":"2004","unstructured":"Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain, 112: 372\u2013380, 2004","journal-title":"Pain"},{"key":"589_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00002820-200010000-00001","volume":"23","author":"SC McMillan","year":"2000","unstructured":"McMillan SC, Tittle M, Hagan S, Laughlin J. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs, 23: 327\u2013336, 2000","journal-title":"Cancer Nurs"},{"key":"589_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9610(01)00783-8","volume":"182","author":"JF Foss","year":"2001","unstructured":"Foss JF, A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg, 182: 19\u201326, 2001","journal-title":"Am J Surg"},{"key":"589_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","volume":"63","author":"A Kurz","year":"2003","unstructured":"Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs, 63: 649\u2013671, 2003","journal-title":"Drugs"},{"key":"589_CR10","first-page":"613","volume":"12","author":"AC Tamayo","year":"2004","unstructured":"Tamayo AC, Diaz-Zuluaga PA. Management of opioid-induced bowel dysfunction in cancer patients. Support Care Cancer, 12: 613\u2013618, 2004","journal-title":"Support Care Cancer"},{"key":"589_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1191\/026921699677653615","volume":"13","author":"MT Fallon","year":"1999","unstructured":"Fallon MT, Hanks GW. Morphine, constipation and performance status in advanced cancer patients. Palliat Med, 13: 159\u2013160, 1999","journal-title":"Palliat Med"},{"key":"589_CR12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1592\/phco.26.7.896","volume":"26","author":"AE Patanwala","year":"2006","unstructured":"Patanwala AE, Abarca J, Huckleberry Y, Erstad BL. Pharmacologic management of constipation in the critically ill patient. Pharmacotherapy, 26: 896\u2013902, 2006","journal-title":"Pharmacotherapy"},{"key":"589_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00520-003-0525-x","volume":"11","author":"E Klaschik","year":"2003","unstructured":"Klaschik E, Nauck F, Ostgathe C. Constipation \u2013 modern laxative therapy. Support Care Cancer, 11: 679\u2013685, 2003","journal-title":"Support Care Cancer"},{"key":"589_CR14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00482-004-0325-3","volume":"19","author":"A Schwarzer","year":"2005","unstructured":"Schwarzer A, Nauck F, Klaschik E. Strong opioids and constipation. Schmerz, 19: 214\u2013219, 2005","journal-title":"Schmerz"},{"key":"589_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-001-0037-7","volume":"5","author":"DM Thorpe","year":"2001","unstructured":"Thorpe DM. Management of opioid-induced constipation. Curr Pain Headache Rep, 5: 237\u2013240, 2001","journal-title":"Curr Pain Headache Rep"},{"key":"589_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11912-007-0034-z","volume":"9","author":"J Thomas","year":"2007","unstructured":"Thomas J. Cancer-related constipation. Curr Oncol Rep, 9: 278\u2013284, 2007","journal-title":"Curr Oncol Rep"},{"key":"589_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.16.2.181","volume":"16","author":"P Holzer","year":"2007","unstructured":"Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs, 16: 181\u2013194, 2007","journal-title":"Expert Opin Investig Drugs"},{"key":"589_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12968\/ijpn.2007.13.1.22776","volume":"13","author":"G Kyle","year":"2007","unstructured":"Kyle G. Constipation and palliative care \u2013 where are we now? Int J Palliat Nurs, 13: 6\u201316, 2007","journal-title":"Int J Palliat Nurs"},{"key":"589_CR19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1191\/026921698674125048","volume":"12","author":"NP Sykes","year":"1998","unstructured":"Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med, 12: 375\u2013382, 1998","journal-title":"Palliat Med"},{"key":"589_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000446-200203000-00027","volume":"102","author":"L Plaisance","year":"2002","unstructured":"Plaisance L, Ellis JA. Opioid-induced constipation. Management is necessary but prevention is better. Am J Nurs, 102: 72\u201373, 2002","journal-title":"Am J Nurs"},{"key":"589_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/104990910502200511","volume":"22","author":"S Wirz","year":"2005","unstructured":"Wirz S, Klaschik E. Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? Am J Hosp Palliat Care, 22: 375\u2013381, 2005","journal-title":"Am J Hosp Palliat Care"},{"key":"589_CR22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1191\/0269216306pm1135oa","volume":"20","author":"RG Twycross","year":"2006","unstructured":"Twycross RG, McNamara P, Schuijt C, Kamm MA, Jordan C. Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study. Palliat Med, 20: 419\u2013423, 2006","journal-title":"Palliat Med"},{"key":"589_CR23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1191\/0269216303pm773oa","volume":"17","author":"M Bennett","year":"2003","unstructured":"Bennett M, Cresswell H. Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning. Palliat Med, 17: 418\u2013422, 2003","journal-title":"Palliat Med"},{"key":"589_CR24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1053\/gast.2000.20390","volume":"119","author":"GR Locke","year":"2000","unstructured":"Locke GR, Pemberton JH, Phillips SF. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology, 119: 1761\u20131766, 2000","journal-title":"Gastroenterology"},{"key":"589_CR25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","volume":"61","author":"SJ Panchal","year":"2007","unstructured":"Panchal SJ, M\u00fcller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract, 61: 1181\u20131187, 2007","journal-title":"Int J Clin Pract"},{"key":"589_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","volume":"23","author":"M Liu","year":"2002","unstructured":"Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage, 23: 48\u201353, 2002","journal-title":"J Pain Symptom Manage"},{"key":"589_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s001010050390","volume":"46","author":"L Latasch","year":"1997","unstructured":"Latasch L, Zimmermann M, Eberhardt B, Jurna I. Treament of morphine-induced constipation with oral naloxone. Anaesthesist, 46: 191\u2013194, 1997","journal-title":"Anaesthesist"},{"key":"589_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","volume":"10","author":"NP Sykes","year":"1996","unstructured":"Sykes NP. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med, 10: 135\u2013144, 1996","journal-title":"Palliat Med"},{"key":"589_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","volume":"84","author":"W Meissner","year":"2000","unstructured":"Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K. Oral naloxone reverses opioid-associated constipation. Pain, 84: 105\u2013109, 2000","journal-title":"Pain"},{"issue":"2","key":"589_CR30","first-page":"CD006332","volume":"16","author":"E McNicol","year":"2002","unstructured":"McNicol E, Boyce D, Schumann R, Carr D. Cochrane Database Syt Rev Apr 16(2): CD006332, 2002","journal-title":"Cochrane Database Syt Rev Apr"},{"key":"589_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000090312","volume":"24","author":"A Lembo","year":"2006","unstructured":"Lembo A. Peripheral opioids for functional GI disease: a reappraisal. Dig Dis, 24: 91\u201398, 2006","journal-title":"Dig Dis"},{"key":"589_CR32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/13543784.14.4.479","volume":"14","author":"P Neary","year":"2005","unstructured":"Neary P, Delaney P. Alvimopan. Expert Opin Investig Drugs, 14: 479\u2013488, 2005","journal-title":"Expert Opin Investig Drugs"},{"key":"589_CR33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","volume":"283","author":"CS Yuan","year":"2000","unstructured":"Yuan CS, Foss JF, O'Connor M, Osinski J, Karrison T, Moss J, Roizen MF. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA, 283: 367\u2013372, 2000","journal-title":"JAMA"},{"key":"589_CR34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.284.11.1383","volume":"283","author":"CS Yuan","year":"2000","unstructured":"Yuan CS, Foss JF. Oral methylnaltrexone for opioid-induced constipation. JAMA, 283: 1383\u20131384, 2000","journal-title":"JAMA"},{"key":"589_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9610(01)00783-8","volume":"182","author":"JF Foss","year":"2001","unstructured":"Foss JF. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg, 182: 19\u201326, 2001","journal-title":"Am J Surg"},{"key":"589_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajog.2006.01.039","volume":"195","author":"TJ Herzog","year":"2006","unstructured":"Herzog TJ, Coleman RL, Guerrieri JP, Gabriel K, Du W, Techner L, Fort JG, Wallin B. A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy. Am J Obstet Gynecol, 195: 445\u2013453, 2006","journal-title":"Am J Obstet Gynecol"},{"key":"589_CR37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","volume":"6","author":"DM Paulson","year":"2005","unstructured":"Paulson DM, Kennedy DT, Donovick RA, Carpenter RL, Cherubini M, Techner L, Du W, Ma Y, Schmidt WK, Wallin B, Jackson D. Alvimopan: an oral, peripherically acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction \u2013 a 21-day treatment-randomized clinical trial. J Pain, 6: 184\u2013192, 2005","journal-title":"J Pain"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-008-0589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-008-0589-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-008-0589-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:03:47Z","timestamp":1559131427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-008-0589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":37,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1007\/s10354-008-0589-9","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}